The revised digital transcutaneous PCO 2 
Introduction
Transcutaneous continuous partial carbon dioxide (PtcCO 2 ) sensors have been used more than twenty years [1] and the devices have been continuously improved. At present, all commercially available PtcCO 2 sensors are electrochemical in nature [2] .
Initially, PtcCO 2 sensors were mainly utilized in neonatology and in critically ill infants in combination with the measurement of transcutaneous partial oxygen tension [3, 4] . Currently, combined assessment of PtcCO 2 and partial oxygen tension using a single earlobe clip sensor is increasingly used in adult patients during noninvasive mechanical ventilation [5] , transportation of critically ill adults [6] , bronchoscopy [7] , sleep studies [8, 9] and pulmonary stress testing [10] . However, sensor preparation, positioning, taping, and the necessity for repeated calibration and repeated changes of the sensor's location because of drifting of the PtcCO 2 signal made handling cumbersome [4] . Additionally, the results of recently performed studies in neonates, infants and adults are controversial in terms of the reliability of these devices [6, [11] [12] [13] . In adults, clip sensors at the earlobe are routinely used because of its intense capillary perfusion. During haemodynamic instability, however, reliability of PtcCO 2 earlobe clip sensors may be restricted because of centralisation of perfusion. Secondary to the earlobe, other skin locations such as the forehead and the cheek might provide adequate perfusion conditions for transcutaneous detection of PtcCO 2 and SpO 2 in critically ill adult patients.
Most recently a revised V-Sign was improved by the material side and the data processing algorithm that characterizes and compensates the drift. Drift specific information is directly stored on the digital sensor itself (in vivo correction). Additionally the equilibration time has been reduced from until 20 min to 3 to 10 min with a mean equilibration time of 5 min. The sensor is heated up to 42°C to achieve local arterialization of the skin at the site of PtcCO 2 monitoring. Prior to application of the sensor to the patient's skin, an automatic calibration of the sensor is performed in vitro.
Afterwards, the sensor is mounted at the skin and the first measurement is performed after allowing a 10-min equilibration time.
The primary aim of this study was to validate the data acquired with the V-Sign TM 2 sensor at the earlobe, forehead and cheek in comparison to arterial carbon dioxide tension (PaCO 2 ) and arterial oxygen saturation (SaO 2 ), measured by co-oximetry, and pulse rate (PR) derived from the electrocardiogram in critically ill patients after cardiac surgery. The secondary aim was to investigate the safety, feasibility and medium term precision of the new V-Sign TM 2 sensor at the different sensor locations.
Material and Methods
With ethics committee approval and written informed consent, 20 patients scheduled for elective cardiac surgery were enrolled in this prospective single-centre trial. Exclusion criteria were non-German-speaking patients, unstable haemodynamics, arrhythmias, and age <18 years. Criteria for terminating a subject's participation were unstable haemodynamics and/or significant arrhythmias, need for re-operation, a serious skin lesion at the measurement site Nellcor N-595. According to the quality criteria for blood gas analyser devices variation in the mean bias of PtcCO 2 and paCO 2 of 3.5% and a variation of LOA of 12.5% was accepted as "good". A mean bias  ± 1 mmHg and LOA  ± 3.5 mmHg were defined as "excellent".
Mean bias  ± 1.5 mmHg and LOA  ±5mmHg were defined as good agreement. Values outside of these definitions were considered "unsatisfactory". For comparison V-Sign SpO2 with SaO2 a good agreement was defined with mean bias ≤ ± 1% and LOA ≤ ± 4%, based on the manufacturers precision of measurements of the Nellcor 595 device. Multiple regression analysis was performed to determine whether blood temperature, pulse rate, cardiac index, skin status mean arterial pressure, the used catecholamines and milrinone significantly influenced PtcCO 2 , PaCO 2 and the difference between PtcCO 2 and PaCO 2 (PtcCO 2 -PaCO 2 ). A p-value less than 0.05 was considered significant. Repeated measures ANOVA were used to estimate between-subjects and within-subject variations. In addition, simple linear regression was performed to assess first differences in transcutaneous and arterial PCO 2 .
Results
Twenty patients were enrolled; their characteristics and procedural parameters are listed in Table 1 . Repositioning of the sensors was necessary in five cases for the earlobe sensor, in three cases for the forehead ring clip sensor, in one case for the cheek ring clip sensor and in three cases for the Nellcor finger clip sensor. For on line data collection a cable bundle of all sensors used was build and placed close the head of the patient. Intensive movement the patients was the reason for repositioning the sensors in most of these cases. In two times a unrealized old membrane of the sensor had to be changed. Two-hundred-ninety-six data pairs (Fig 3a-c) . The corresponding sensitivity/specificity to detect changes of PaCO 2 was 87/82 %, 79/78 % and 83/78 %, respectively. P E CO 2 correlated only moderately with PaCO 2 and the agreement was poor ( Table 2) . Fig 4a-c) . However, the Nellcor device showed the smallest detection error and the best agreement with (Fig 5a-c) , whereas the agreement of the Nellcor device with the ECG was poor ( Table 2) . No reddening or higher degrees of skin irritation were found in any patient neither during the study period nor following removal of the sensors even after 12 hours.
End-expiratory carbon dioxide correlated poorly with PaCO 2 , had relevant bias and wide limits of agreement ( Table 2) .
Discussion
In this study we evaluated accuracy and precision of the recently revised V-Sign TM 2 sensor at three different sites of application on the head (earlobe, forehead and cheek) in adult patients during recovery from cardiac surgery.
The main results of the study were (i) the best site for PtcCO 2 measurement is the earlobe, (ii) at the earlobe, an excellent agreement was found between PtcCO 2 and PaCO 2 with only a slight overestimation of PaCO 2 , (iii) no statically significant drift was observed at either one of the three sensor locations, and the sensitivity and specificity to detect changes of PaCO 2 was good, (iv) the rate of detection failures of SpO 2 was high, and the agreement of SpO 2 values with SaO 2 was unsatisfactory (v) PR detected with the V-Sign TM 2 sensor showed an excellent agreement at all sensor locations with the ECG-derived PR, but detection failures were found in 5 to 10%, with the lowest rate of detection failure at the earlobe.
Because of the large capillary network and good access way, the earlobe is the most favourite site in adults to attach a sensor that uses electrochemical technology for measuring carbon dioxide tension transcutaneously. It is well known, that cutaneous microcirculation shows a significant heterogeneity [16] . The supraorbital skin region, where the forehead sensor was attached, is supplied by the supraorbital artery, a branch of the internal carotid artery. The dependency of the supraorbital skin perfusion on the blood flow rate through the internal carotid was recently demonstrated by Hove and co-workers [17] , using near infra-red spectroscopy in patients undergoing carotid endarterectomy. Supraorbital skin perfusion seems to be excluded from the centralization of blood flow accompanying low cardiac output states and might therefore be an optimal detection surface. For this reason we attached the sensors at the earlobe, the forehead and the cheek and expected better detection of PCO 2 and SpO 2 at the forehead. Thus it is surprising and not easily explicable that the earlobe appeared to be the best area for applying the electrochemical PtcCO 2 and conventional PaO 2 sensors in the present investigation. The inflammatory response that was present postoperatively in most patients, the necessity of vasopressor support and the lack of centralization might be a possible explanation for this finding. Rodriguez and co-workers [11] recently evaluated PtcCO 2 monitoring in critically ill adults and reported that only major cutaneous vasoconstriction considerably influenced the accuracy of PtcCO 2 measurements, whereas application of catecholamines, respiratory support and mild hypothermia did not exert substantial interference. In the present study exploration of the skin status until 12 hours after removal the sensors showed no signs of low perfusion.
Monitors for combined continuous transcutaneous measurements of carbon dioxide tension and oxygen saturation have been investigated in recent years in healthy volunteers [18] , during major surgery [19] , in patients with severe pulmonary disease [5, 20] and in critically ill adults [11, 12, 21] , but the results regarding reliability were not conclusive. In 13 spontaneously breathing, not intubated patients in the early postoperative period, Fanelli and co-workers [21] reported only a unsatisfactory agreement of PtcCO 2 measured with a previous version of the V-Sign TM 2 earlobe sensor and PaCO 2 measured by co-oxymetry. The study is however limited in its explanatory power, since a small and particularly heterogeneous group of patients was included and because of methodological confinement of blood sampling. In a previous study [12] , using an older version of the V-Sign [5, 20] and is attributed primarily to the anaerobic factor, caused by heating the sensor area, and secondary to CO 2 production of living epidermal cells.
During the 6 hours study period, 16 of the 20 patients were breathing spontaneously while being supported by a respirator, the lungs of two patients were ventilated, and two patients were extubated three hours after admission. Intra-individual analysis of the agreement between PtcCO 2 and PaCO 2 data pairs collected after extubation of the two patients showed no considerable differences to the patients whose lungs were ventilated. These findings are supported by a study most recently published by Maniscalco and colleagues [22] and performed in severely obese and clinically unstable patients using the TOSCA device (Linde Medical Sensors AG, Basel, Switzerland). These authors reported good agreement of PtcCO 2 and PaCO 2 in both spontaneously breathing and ventilated patients. The finding, that dobutamine has an impact on the bias PtcCO 2ear and PaCO 2 might be explained by improvement of the microcirculation at the ear lobe, which leads to a higher PtcCO2, caused by higher tissue CO 2 production. Since dobutamine in this study was only applied in the low dose range, it is not excluded, that doses of dobutamine above the low range may significantly interfere with the accuracy of the PtcCO 2 measurement at the ear lobe. P E CO 2 correlated only moderately with PaCO 2 and with PtcCO2 and the agreements were poor, indicating that PtcCO 2 better detects changes in the ventilation state of the patients than P E CO 2 during the recovery period.
Most investigators focused their reports on accuracy and precision of PtcCO 2 , whereas the reliability of oxygen saturation measurements was not or less discussed. Rohling and coworkers [25] reported excellent agreement of transcutaneously measured SpO 2 using the TOSCA device and SaO 2 in anaesthetized adult patients. Similar results were found in anaesthetized pediatric patients by Dullenkopf and co-workers [26] with a mean bias and limits of agreement of -0.63% and -3.4 / +2.1% respectively. In patients assessed for longterm oxygen therapy, Schafroth Török and colleagues [20] recently confirmed these results using a previous version of the V-Sign TM 2 sensor. However, this investigation was performed in medical patients with presumably constant body temperature attending lung function tests for assessment of home oxygen therapy. In a previous study [12] using the same sensor as Schafroth Török and colleagues [20] we reported unacceptably high limits of agreement for SpO 2 and SaO 2 in patients with stable haemodynamics during recovery after cardiac surgery.
Although detection of transcutaneous oxygen saturation and pulse rate was considerably improved with the revised V-Sign TM 2 sensor, the rate of detection failure still ranged between 10 to 25% and thus was too high at all sensor locations. Additionally, the limits of agreement of SpO 2 did not meet predefined criteria. The best results were found when the revised VSign TM 2 sensor was attached at the earlobe, but the rate of detection failures was still 10%.
In healthy adult volunteers, Mannheimer and colleagues [27] reported statistically significant degradation of reading accuracy of SpO 2 , measured by reflectance pulse oximetry. They recommended to attach the sensor at the lower part of the forehead directly over the eyebrow and slightly lateral to the eye to avoid possible impact of vasculature on SpO 2 readings. In the current investigation we cannot exclude that pulsatile vasculature at the forehead and cheek had an impact on accuracy of SpO 2 detection. Remarkably, the rate of detection failure for pulse rate, measured with the revised V-Sign TM 2 sensors, ranged between 5 to 10% and, thus, was considerably lower than that for SpO 2 . The lowest rate of detection failure of 5% and a good agreement with a bias of +1.2 bpm and limits of agreement of -3.3 and +5.8 were found with the revised sensor attached to the earlobe. The lowest rate of detection failure of 2% for SpO 2 and PR and an excellent agreement of SpO 2 and SaO 2 were found with the Nellcor N-595 device using a finger clip. These findings confirmed the results of our previous study [12] .
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